Magnetar Financial’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,124,807
Closed -$16.8M 940
2022
Q4
$16.8M Buy
+1,124,807
New +$15.6M 0.28% 94

Magnetar Financial's AVEO Position: Q1 2023 in Review

Magnetar Financial sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 1,124,807 shares — an estimated $16.8M sold.

Magnetar Financial first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $16.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Magnetar Financial reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Magnetar Financial sold 1,124,807 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $16.8M.
  • Magnetar Financial first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Magnetar Financial's AVEO Pharmaceuticals, Inc. position peaked at $16.8M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Magnetar Financial's 13F filing for Q1 2023, filed 15 May 2023.